Bristol-Myers Squibb Falls 1.06% as Four-Day Losing Streak Drags Shares Down 5.84% on Bearish Technicals

Generated by AI AgentAinvest Technical Radar
Tuesday, Oct 7, 2025 10:31 pm ET3min read
BMY--
Aime RobotAime Summary

- Bristol-Myers Squibb (BMY) fell 1.06% in a four-day losing streak, with total losses reaching 5.84%.

- Technical indicators show bearish momentum, including a descending candlestick pattern and key support at $44.25–$44.66.

- RSI remains in oversold territory (<30) without reversal signals, while moving averages confirm a sustained downtrend.

- A backtested RSI-based strategy underperformed significantly (-43.79 excess return), reinforcing the stock's entrenched bearish bias.

Bristol-Myers Squibb (BMY) has experienced a 1.06% decline in its most recent session, marking four consecutive days of losses with a total drawdown of 5.84%. This sustained bearish momentum, coupled with mixed signals from technical indicators, warrants a detailed analysis of price structure, momentum dynamics, and volatility patterns to assess potential near-term outcomes.

Candlestick Theory

The recent price action reveals a bearish bias, with a descending pattern forming over the past four days. A key support level appears to be consolidating around $44.66–$44.25, where the stock found temporary buying interest on October 3–7. A breakdown below this range could target the next major support at $43.25, identified as a prior trough on September 26. Resistance levels include the recent high of $45.91 (October 6) and the 50-day moving average (currently estimated at $45.80 based on historical data). A bearish engulfing pattern on October 2, where the price closed significantly below the prior session’s low, suggests continued downward pressure. However, the absence of a strong reversal candlestick (e.g., a hammer or bullish engulfing) implies the trend may persist unless a breakout above $45.91 occurs.

Moving Average Theory

Short-term and long-term moving averages confirm a bearish bias. The 50-day MA is likely above the current price, indicating a downtrend in the intermediate term. The 100-day and 200-day MAs are expected to be even higher, reinforcing a longer-term bearish structure. A crossover of the 50-day and 100-day MAs to the downside (if confirmed) would signal a potential acceleration in the decline. However, the 200-day MA’s position above the 100-day MA suggests the trend remains intact for now. Traders should monitor for a "death cross" (50-day MA crossing below the 200-day MA), which could amplify bearish sentiment.

MACD & KDJ Indicators

The MACD histogram has contracted, with the MACD line trending below the signal line, confirming bearish momentum. A potential bearish crossover (MACD line crossing below the signal line) could heighten the likelihood of further declines. The KDJ (Stochastic) oscillator shows %K and %D lines in oversold territory (<30), but the divergence between the oscillator and price action (i.e., %K failing to rise despite lower lows) suggests the oversold condition may not trigger a reversal. This divergence warns of a potential continuation of the downtrend rather than a rebound.

Bollinger Bands

Volatility has contracted recently, with the price trading near the lower Bollinger Band ($44.25–$44.66 range). This "squeeze" pattern historically precedes a breakout, but the direction remains uncertain. If the price breaks below the lower band, it could signal increased volatility and a deepening of the bearish phase. Conversely, a rebound above the middle band ($45.14) might indicate a temporary consolidation phase. The bands’ width has narrowed, suggesting a low-probability scenario for a sharp reversal.

Volume-Price Relationship

Volume patterns show inconsistency, with elevated volume on October 1 (a 5.17% rally) followed by lower-volume bearish sessions. This suggests that the recent downtrend lacks strong institutional selling pressure, which could limit the magnitude of further declines. However, the absence of a surge in volume during the recent selloff implies weak conviction among sellers, potentially leading to a shallow correction. Traders should watch for a spike in volume during a rebound, which could signal a short-covering rally.

Relative Strength Index (RSI)

The RSI is currently below 30, indicating an oversold condition. However, in a strong downtrend, the RSI can remain in oversold territory for extended periods without a reversal. A divergence between the RSI and price action (e.g., RSI failing to rise while the price makes new lows) strengthens the bearish case. A potential reversal would require the RSI to rise above 50 with increasing volume, but this is unlikely without a catalyst such as positive earnings or news.

Fibonacci Retracement

Key Fibonacci retracement levels from the recent high of $48.58 to the low of $44.25 are at 38.2% ($46.33), 50% ($46.41), and 61.8% ($46.49). These levels could act as dynamic resistance if the price attempts to rebound. A break above $46.49 would suggest a potential consolidation phase, while a failure to hold above these levels would reaffirm the bearish trend.

Backtest Hypothesis

The historical backtest of a strategy purchasing BMYBMY-- when RSI falls below 30 and holding for five days shows underperformance relative to the benchmark. From 2022 to 2025, the strategy returned 5.29%, significantly lagging the benchmark’s 49.07%. The negative excess return (-43.79%) and low Sharpe ratio (0.13) indicate poor risk-adjusted returns, suggesting the oversold RSI strategy is ineffective for BMY in this context. This aligns with the current technical environment, where RSI remains in oversold territory without triggering a reversal. Investors should avoid relying solely on RSI signals for long entries, as the stock’s bearish trend appears entrenched.

If I have seen further, it is by standing on the shoulders of giants.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet